These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21820798)

  • 1. Detection of TFPI2 methylation in the serum of colorectal cancer patients.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of TFPI2 methylation in the serum of gastric cancer patients.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2011 Nov; 31(11):3835-8. PubMed ID: 22110206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer.
    Hibi K; Goto T; Kitamura YH; Yokomizo K; Sakuraba K; Shirahata A; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2010 Apr; 30(4):1205-7. PubMed ID: 20530429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2012 Mar; 32(3):787-90. PubMed ID: 22399594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.
    Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H
    Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
    Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China.
    Zhang J; Yang S; Xie Y; Chen X; Zhao Y; He D; Li J
    Cancer Epidemiol; 2012 Feb; 36(1):73-7. PubMed ID: 21621497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
    Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer.
    Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Yokomizo K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2011 Sep; 31(9):2889-92. PubMed ID: 21868534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vimentin methylation as a marker for advanced colorectal carcinoma.
    Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
    Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
    Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT
    Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MGMT gene is aberrantly methylated from the early stages of colorectal cancers.
    Hibi K; Goto T; Mizukami H; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Hepatogastroenterology; 2009; 56(96):1642-4. PubMed ID: 20214209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancer.
    Hibi K; Nakao A
    Anticancer Res; 2006; 26(1A):55-8. PubMed ID: 16475679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma.
    Nakayama G; Hibi K; Kodera Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(5A):3367-70. PubMed ID: 17970082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
    Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J
    Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.